Study Finds AppliedVR Platform Feasible, Scalable and Effective.

INTERNET BUSINESS NEWS-(C)1995-2020 M2 COMMUNICATIONS

AppliedVR, a pioneer advancing the next generation of digital medicine, has announced results from the first randomized controlled trial (RCT), evaluating virtual-reality-based (VR) therapy for self-management of chronic pain at home, the company said.

The study, which was published in JMIR-FR, found that a self-administered, skills-based VR treatment program was not only a feasible and scalable way to treat chronic pain, it also was effective at improving on multiple chronic pain outcomes.

With the COVID-19 pandemic severely disrupting Americans' ability to seek care in clinical settings safely, demand for home-based virtual care has skyrocketed, forcing providers, insurers and policymakers to expand access to digital medicine. Today's study sought to demonstrate the feasibility and efficacy of people using the AppliedVR program at home on themselves to manage their chronic pain. The team conducted a rigorously designed study that compared VR to the same treatment...

To continue reading

Request your trial